Consumer and regulation guide | Current as of 13 October 2026 | Not medical advice.
In brief: CBD remains a fast-changing regulatory area in the UK. The Food Standards Agency (FSA) has recommended that ministers consider authorising three highly purified CBD food products under specified conditions. The recommendations are a milestone, but they are not the same as a blanket authorisation for every CBD oil, gummy, drink or supplement on sale. Consumers and retailers should distinguish CBD’s legal status as a novel food from the rules for controlled cannabinoids and prescription medicines.
What is CBD?
Cannabidiol, usually shortened to CBD, is one of many cannabinoids found in cannabis and hemp. It is not the same substance as THC, the cannabinoid primarily associated with intoxication. However, a product’s label and marketing do not guarantee that it contains only CBD. Some products may contain trace or undeclared THC or other cannabinoids, which can create legal and safety concerns.
CBD food products are treated as novel foods under the UK framework. In general, a novel food requires authorisation before it can be legally placed on the market. This means that the question is not simply whether CBD itself is controlled as a drug; the regulatory status of a food containing CBD is a separate matter.
What changed in September 2026?
In September 2026, the FSA published recommendations to ministers concerning three applications: synthetic CBD and two CBD-isolate products. The FSA’s assessment said these highly purified products had been found safe under their proposed conditions of use, including a maximum daily dose of 10mg for adults. The recommendations propose detailed specifications and labelling conditions, including limits for THC and other controlled cannabinoids.
The FSA described the possible authorisations as a regulatory first for Great Britain. However, the final decisions rest with ministers. As of this article’s date, the recommendations should not be interpreted as proof that all CBD foods have been authorised. Consumers and businesses should check the current official register and final decisions rather than relying on headlines alone.
What does the 10mg guidance mean?
The FSA advises healthy adults to limit CBD consumption from food to no more than 10mg per day. This is a precautionary acceptable daily intake based on the evidence assessed by the agency. It is not a recommended therapeutic dose and should not be read as advice that everyone should take CBD.
Consumers need to add together the CBD they consume from different products. A person might use oil, a drink and a gummy on the same day, without realising that each contributes to the total. Product labels should be checked for the amount per serving, and serving size should not be confused with the total amount in a bottle or packet.
The FSA advises children under 18, people who are pregnant or breastfeeding or trying to conceive, and people taking medication to avoid CBD unless under medical direction. The agency has highlighted uncertainty about long-term safety, reproductive and developmental effects, and interactions with medicines. People with health concerns should discuss products with a qualified healthcare professional.
Why are novel-food rules important?
Novel-food authorisation is intended to assess safety and set conditions for use, rather than simply judge whether a product is popular. The assessment can include manufacturing details, composition, exposure, toxicology and specifications designed to keep contaminants and controlled cannabinoids within limits. Authorisation of one product or formulation does not automatically cover a different extract, manufacturing process, dose or combination of ingredients.
The FSA has also highlighted the need for accurate labelling and responsible marketing. A CBD food should not be promoted with unsubstantiated claims that it treats pain, anxiety, insomnia or disease. Food products are not the same as licensed medicines, and claims that imply medical treatment can breach regulatory rules. Consumers should be wary of testimonials and influencer posts that promise a cure.
Can CBD make you high or affect a drug test?
CBD itself is not generally considered intoxicating in the way THC is. But products may contain trace amounts of THC or other controlled cannabinoids, including where labels make broad claims such as “THC-free”. Standard drug tests focus on substances such as THC rather than CBD itself, but exposure from a product cannot be assessed solely from marketing language. Anyone subject to workplace, sporting or legal testing should be particularly cautious about products with unclear composition.
How should consumers check a CBD product?
- Check the FSA’s current CBD Public List and official guidance.
- Read the amount of CBD per serving and calculate the total daily intake from all products.
- Look for a clear business name, contact details, ingredients and batch information.
- Be wary of claims that a food product cures or treats a medical condition.
- Do not assume that an “all natural” label means a product is safe or authorised.
- Ask a healthcare professional before using CBD if you take medication or have a relevant health concern.
What does this mean for CBD businesses?
Businesses should monitor the official authorisation process, check whether their specific product is included in the relevant public list or final authorisation, and avoid treating a related product’s status as a substitute for their own compliance. Labelling, product specifications, permitted claims and supply-chain records all matter. The regulatory picture may evolve as ministers consider recommendations and the FSA continues assessing applications.
Frequently asked questions
Is every CBD product legal in the UK?
No. CBD foods are subject to the novel-food framework, and authorisation is product-specific. Check the current official guidance and public list.
Is 10mg the amount I should take?
No. It is the FSA’s maximum daily intake guidance for healthy adults, not a recommendation to use CBD or a treatment dose.
Have the three proposed products received final authorisation?
The September 2026 FSA document contains recommendations to ministers. Check the latest official record for any final decision after that date.
Editorial note: This article summarises the regulatory position as published on 13 October 2026. Regulations and official lists can change; always check the latest government guidance.